AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04608292 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood sampling
Description: Participants will have a peripheral arterial and peripheral venous line inserted and periodic arterial and venous blood samples will be measured for blood alcohol content.
Study NCT06517368 — intervention group
Intervention type: DEVICE
Intervention: MRI, Ultrasound
Description: The patients will undergo both B-mode and sonoelastographic examinations in the supine and lateral decubitus position and will perform during breath-holding after deep inspiration. The elastogram was displayed over the B-mode image in a color scale: red (greatest strain, softest tissue component), green (average strain, intermediate tissue component), and blue (no strain, hardest tissue component) Patients will be examined by MRI with diffusion images and ADC values.
Study NCT05182424 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Myndlift BPT App & As-Needed Therapist Support
Description: BPT is based on social learning and operant conditioning principles in which parents are instructed to utilize methods to facilitate positive behaviors in their child and reduce challenging behaviors. Myndlift BPT translates established content and processes into a digital format to be delivered through a mobile app. Myndlift content consists of 10 components, designed to be completed in a self-directed manner by parents, over the course of approximately 10 weeks (total weeks depends upon parent's pace through the program).~In this project, trained and supervised doctoral- and masters-level students will serve as study therapists and meet with parents via a secured, password-protected Zoom platform to introduce parents to the Myndlift BPT (first session before start of the BPT), to support and problem solve BPT skills acquisition (during the Myndlift BPT), and at the end of the Myndlift BPT (to review the intervention content and consider the maintenance of skills).
Study NCT05182424 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Myndlift BPT App & As-Needed Therapist Support
Description: BPT is based on social learning and operant conditioning principles in which parents are instructed to utilize methods to facilitate positive behaviors in their child and reduce challenging behaviors. Myndlift BPT translates established content and processes into a digital format to be delivered through a mobile app. Myndlift content consists of 10 components, designed to be completed in a self-directed manner by parents, over the course of approximately 10 weeks (total weeks depends upon parent's pace through the program).~In this project, trained and supervised doctoral- and masters-level students will serve as study therapists and meet with parents via a secured, password-protected Zoom platform to introduce parents to the Myndlift BPT (first session before start of the BPT), to support and problem solve BPT skills acquisition (during the Myndlift BPT), and at the end of the Myndlift BPT (to review the intervention content and consider the maintenance of skills).
Study NCT04961879 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Reversed Cross Finger Flap
Description: distal dorsal finger defect will be reconstructed by reversed cross finger flap~- reversed cross finger flap is a modified cross finger flap harvested from an adjacent finger .
Study NCT04961879 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: reversed island homo-digital flap
Description: distal dorsal finger defect will be reconstructed by reversed island homo-digital flap~- this flap is harvested from the same finger .
Study NCT05113316 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Messy Memories App
Description: The Messy Memories mobile app is an intervention targeting stress-related problems based on practices with proven effectiveness, to overcome barriers and provide access to evidence-informed intervention strategies aimed to improve mental health in frontline healthcare workers.~The app allows the user to self-administer exposure therapy techniques outside of the traditional psychotherapy context. The Messy Memories app was initially released in a written form for self-help, but with widespread use of smartphones, a mobile application has the potential to further reduce barriers and increase access to care among frontline healthcare workers. The current study proposes to examine this newly developed application for usability and feasibility in a small sample of frontline healthcare workers (Phase I) and then test efficacy of the application in a larger-scale RCT (Phase II) where the application will be compared to a TAU condition.
Study NCT06203483 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Adductor canal block
Description: A linear ultrasound probe will be placed medial to the patella, the probe will be advanced to cephalad, and the superficial femoral artery will be visualized. The block site will be confirmed by injecting 5 ml of saline around the saphenous nerve in the subsartorial region under ultrasound guidance. Then, 30 ml of local anesthetic solution containing 0.25% bupivacaine (Marcain 0.5% AstraZeneca, England) will be administered.
Study NCT06203483 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PENG block
Description: The probe will be placed at the anterior superior level of spina iliaca, parallel to the inguinal ligament. The probe will be scanned gradually towards the caudal. After the anterior inferior of the spina iliaca is visible, the probe will be slightly turned medially until the hyperechoic shadow of the superior pubic ramus is visible. The psoas muscle tendon will be visualized above the superior pubic ramus, then 5 ml of saline will be injected under the psoas tendon and the block location will be confirmed. After that 30 ml of 0.25% bupivacaine will be administered.
Study NCT05494268 — intervention group
Intervention type: DRUG
Intervention: Carbohydrate
Description: Preoperative Carbohydrate Loading Drink
Study NCT05386147 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flourish HEC Vaginal Care System (contains a class II medical device plus other unregulated components)
Description: see arm description
Study NCT05280665 — intervention group
Intervention type: OTHER
Intervention: Specialization
Description: * Who had undergone professional training in gastric cancer surgery in specialized gastric cancer centers (in Japan or Korea),~* Who identified themselves as primarily gastric surgeons during the study period~* Whose annual gastric cancer surgery volume is more than 21
Study NCT06425653 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise Program
Description: In the intervention group in addition to the standard protocol, an exercise program intervention was applied and after the initial interview the Exercise Program DVD was provided through mobile phone. All patients were evaluated 4 times: at baseline, at the 4th week (first visit), at the 8th week (second visit) and at the 12th week (final visit) after randomization
Study NCT04878107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab (AiRuiKa™), a programmed cell death 1 (PD-1) inhibitor being developed by Jiangsu Hengrui Medicine Co. Ltd
Study NCT04878107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Apatinib \[Aitan® (brand name in China)\], also known as rivoceranib, is a novel, small molecule, selective vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor
Study NCT04878107 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel injection
Description: Docetaxel is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug
Study NCT04878107 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: SBRT
Description: Stereotactic body radiation therapy (SBRT) is a cancer treatment that delivers extremely precise, very intense doses of radiation to cancer cells while minimizing damage to healthy tissue. SBRT involves the use of sophisticated image guidance that pinpoints the exact three-dimensional location of a tumor so that the radiation can be more precisely delivered to cancer cells.
Study NCT04878107 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: Stereotactic body radiation therapy (SBRT) is a cancer treatment that delivers extremely precise, very intense doses of radiation to cancer cells while minimizing damage to healthy tissue. SBRT involves the use of sophisticated image guidance that pinpoints the exact three-dimensional location of a tumor so that the radiation can be more precisely delivered to cancer cells.
Study NCT04878107 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: LDRT
Description: low dose radation therapy
Study NCT05814718 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: modified BEAM
Description: Mitoxantrone liposome 24 mg/m2，ivgtt，d-7；BCNU 300 mg/m2，ivgtt，d-6； Ara-C 200 mg/m2 q12h，ivgtt，d-5- -2； Vp16 200 mg/m2 ，ivgtt，d-5- -2；
Study NCT05814718 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BEAM
Description: BCNU 300 mg/m2，-7d； Vp16 200 mg/m2，-6～-3d； Ara-C 100mg/m2 q12h，-6～-3d； Mel 140mg/m2，-2d
Study NCT06072625 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Extra virgin organic olive oil (ULTRA PREMIUM)
Description: Babies who have fully enteral feeding will take oral, 1 ml/kg/day of extra virgin olive-oil
Study NCT05158530 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic training
Description: Aerobic training ( with cycle ergometer, 5-minute warm-up 15 - 30 minute cycle +5 minute cooldown) 40%-60% intensity calculated through Karvonen formula 3 days/ week
Study NCT05158530 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Pulmonary Exercises
Description: 4 weeks protocol~1. Deep breathing Exercises\* 10 Reps 3 sets~2. Postural drainage (10 minutes \* 2 sets /day)~3. Incentive spirometry\* 10 Reps 3 sets~4. Bed activities (Active ankle and hand pumping exercise \* 10 Reps 3 sets)
Study NCT06339606 — intervention group
Intervention type: OTHER
Intervention: Biospecimen collection
Description: Biospecimens, including maternal blood and cervical mucus will be collected serially during pregnancy. After delivery tissue samples from the placenta and umbilical cord blood will be collected.
Study NCT05056558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baricitinib
Description: Continued standard of care (SOC) together with oral 4 mg Baricitinib tablet from day 1 to day 14
Study NCT05056558 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Continued standard of care (SOC) together with oral placebo tablet from day 1 to day 14
Study NCT05711875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) glasses
Description: During the Non Stress Test (NST), the pregnant women in the experimental group watched a video of nature scenery with Virtual Reality (VR) glasses for 10 minutes
Study NCT05316493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Intervention (ILI)
Description: dietary guidance, exercise guidance, lifestyle intervention
Study NCT05316493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Megestrol Acetate 160 MG Oral Tablet
Description: enrolled participants will take Megestrol Acetate 160mg daily
Study NCT05316493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg
Description: enrolled patients will be treated with LNG-IUS.
Study NCT05881512 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Upper Airway Stimulation Device
Description: Multiple frequency stimulation of the hypoglossal nerve
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiorespiratory fitness
Description: Cardiopulmonary exercise testing
Study NCT04674748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB086550
Description: Each Participant will be treated at the specified dose level with a minimum of 3 subjects at each dose level. After the RP2D of INCB086550 is identified, the dose level will be expanded to better characterize the safety and tolerability and PK.
Study NCT06192836 — intervention group
Intervention type: PROCEDURE
Intervention: Manual Removal 1
Description: 1. Placenta will be removed manually~2. Uterine incision will be repaired as double layered~3. No uterine massage will be performed
Study NCT06192836 — intervention group
Intervention type: PROCEDURE
Intervention: Manual Removal 2
Description: 1. Placenta will be removed manually~2. Uterine incision will be repaired as double layered~3. Uterine massage will be performed for one minute duration, after uterine incision is closed
Study NCT06192836 — intervention group
Intervention type: PROCEDURE
Intervention: Controlled Cord Traction 1
Description: 1. Placenta will be delivered via controlled cord traction~2. Uterine incision will be repaired as double layered~3. No uterine massage will be performed
Study NCT06192836 — intervention group
Intervention type: PROCEDURE
Intervention: Controlled Cord Traction 2
Description: 1. Placenta will be delivered via controlled cord traction~2. Uterine incision will be repaired as double layered~3. Uterine massage will be performed for one minute duration, after uterine incision is closed
Study NCT06192836 — intervention group
Intervention type: PROCEDURE
Intervention: Controlled Cord Traction+Uterine Massage 1
Description: 1. Placenta will be delivered via controlled cord traction plus uterine massage~2. Uterine incision will be repaired as double layered~3. No uterine massage will be performed after placental delivery
Study NCT06192836 — intervention group
Intervention type: PROCEDURE
Intervention: Controlled Cord Traction+Uterine Massage 2
Description: 1. Placenta will be delivered via controlled cord traction plus uterine massage~2. Uterine incision will be repaired as double layered~3. Additional uterine massage for one minute duration will be performed after uterine incision is closed
Study NCT06444945 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heating pad
Description: Heating pad will be used for heating purpose.
Study NCT06444945 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation(TENS)
Description: TENS is used for symptomatic pain relief
Study NCT06444945 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mulligan mobilization with movement (MWM)
Description: It provides short term pain relief and to restore pain-free, functional movements by achieving full range at the joint
Study NCT06444945 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Kaltenborn joint mobilization
Description: The purpose of joint mobilization is to restore normal, painless joint function. In restricted joints, this involves the restoration of joint play to normalize the roll-gliding that is essential to active movement.
Study NCT06444945 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resistance Training exercise
Description: Resistance training increases muscle strength by making your muscles work against a weight or force.
Study NCT04340349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Sulfate
Description: A daily low dose of Hydroxychloroquine Sulfate. Increase the endosomal pH and inhibits of ACE2 glycosylation receptor.
Study NCT04340349 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydroxychloroquine Sulfate
Description: A daily low dose of Hydroxychloroquine Sulfate. Increase the endosomal pH and inhibits of ACE2 glycosylation receptor.
Study NCT04340349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bromhexine 8 MG
Description: TMPRSS2 blocker
Study NCT04340349 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bromhexine 8 MG
Description: TMPRSS2 blocker
Study NCT05975736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Search only for masses
Description: Participants search the simulated mammogram for simulated masses.
Study NCT05975736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Search only for calcifications
Description: Participants search the simulated mammogram for simulated calcifications.
Study NCT05975736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Search for both together
Description: Search the simulated mammogram for both simulated masses and simulated calcifications at the same time.
Study NCT05975736 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Search for one after the other
Description: Search the simulated mammogram for first for simulated masses and then for simulated calcifications sequentially (or vice versa).
Study NCT01799122 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mini Arc Precise Pro and Trans vaginal obturator sling (TVT-0)
Study NCT05408572 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SON-1010 (IL12-FHAB)
Description: SON-1010 is a single-chain human IL-12 cytokine linked to a single-chain variable region known as the FHAB.
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Lung function
Description: Body plethysmography
Study NCT06184685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sahasthara Microemulsion
Description: All patients were instructed to treat the knee with 2 ml, 3x/day, for 28 days. Each of the patients received the same appearance of drug packaging, which was not revealed until data analysis was completed, or medical emergency conditions would require an unblinding.
Study NCT06184685 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac Microemulsion
Description: All patients were instructed to treat the knee with 2 ml, 3x/day, for 28 days. Each of the patients received the same appearance of drug packaging, which was not revealed until data analysis was completed, or medical emergency conditions would require an unblinding.
Study NCT05433701 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy
Description: * Verify the setup position and respiration of patients as in the simulation CT image.~* To precisely align the tumor prior to each treatment, cone-beam CT and gated fluoroscopy using the On-board Imager mounted on the linear accelerator are performed.~* The Real-time Position Management system is used to monitor the accuracy of breathing phase during treatment.
Study NCT05433701 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Radiofrequency Ablation
Description: - RFA are performed under local anesthesia or monitored anesthesia care with either a 15-gause or 17-gause internally cooled electrode, depending on the size of the tumor.
Study NCT05128071 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Progesterone
Description: Randomized to 400 mg (200 mg twice daily) oral micronized progesterone daily
Study NCT05128071 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Randomized to placebo twice daily
Study NCT05761288 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intraoperative microbreaks and exercises
Description: Intraoperative microbreaks and exercises will include standardized breaks lasting approximately 1.5-2 minutes. During these breaks, surgeons will perform a set of targeted stretches or exercises while remaining sterile. Intervention exercises include: chest and shoulder opener elbows in pockets, chin tuck, neck rotation, squat with truncal rotation (chair pose with prayer), and forward bend.
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Muscular strength and balance tests
Description: Handgrip strength test, mid-thigh pull test and standing balance test in static tandem stance
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Micro- and macrovascular endothelial function and cardiac function
Description: Measurement of flow-mediated dilation, static and dynamic retinal vessel analysis, echocardiography
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sampling and analysis
Description: Blood sampling by venepuncture
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Physical activity
Description: Physical activity surveillance using accelerometers
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Questionnaires
Description: Global physical activity questionnaire (GPAQ), short-form 8 health survey (SF-8), barriers to physical activity, fatigue assessment scale (FAS), modified medical research council dyspnea scale (mMRC), depression, anxiety, and stress scale (DASS21), post-COVID-19 syndrome symptoms
Study NCT05118711 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Body composition
Description: Dual-energy x-ray absorptiometry (DXA)
Study NCT05097833 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Saint Francis Fatherhood FIRE Program
Description: Fathers receive an enhanced series of pro-parenting, relationship, and economic stability workshops over 16 weeks. Workshop series are based on a diverse curricula including a combination of either 24/7 Dad or Parent Project and Connections to Success and the Nurturing Fathers enhancement program.
Study NCT05097833 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Services as Usual Saint Francis Fatherhood FIRE Program
Description: Fathers receive the services as usual approach which includes a series of pro-parenting, relationship, and economic stability workshops over 13 weeks. Workshop series are based on a diverse curricula including a combination of either 24/7 Dad or Parent Project and Connections to Success.
Study NCT06184542 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: DTacP (one-dose booster)
Description: Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine of 0.5mL on Day 0
Study NCT04907253 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Quercetin
Description: 500 mg twice daily
Study NCT04907253 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: twice daily